Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer

Abstract Ovarian cancer remains the most lethal gynecological malignancy. Despite the approval of promising targeted therapy such as bevacizumab and PARP inhibitors, 5-year survival has not improved significantly. Thus, there is an urgent need for new therapeutics. New advancements in therapeutic st...

Full description

Saved in:
Bibliographic Details
Main Authors: Julia Hillmann, Nicolai Maass, Dirk O. Bauerschlag, Inken Flörkemeier
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Medicine
Subjects:
Ovarian cancer
Therapy
Hallmarks of cancer
Online Access:https://doi.org/10.1186/s12916-024-03826-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items